#PharmaTimes #pharma #pharmaceuticals #BoehringerIngelheim #oncology #Subcutaneouspembrolizumab #NHS #NHShospitals #intravenousdelivery #immunotherapy #MHRA #immunecheckpointinhibitor #healthcareprofessionals #clinicianpreparationtime #NHSproductivity #oncologypatients
zurl.co/FWaFL
zurl.co/FWaFL
Subcutaneous pembrolizumab begins rollout across NHS hospitals - PharmaTimes
New one‑to‑two‑minute injection offers faster option for patients
pharmatimes.com
April 30, 2026 at 9:39 AM